INS and diabetes mellitus: The Diabetes Control and Complications Trial (DCCT) indicates that sustained C-peptide concentrations are associated with lower rates of hypoglycemia, lower HbA1c levels, reduced insulin dose requirements and lower incidents of diabetes complications, such as retinopathy and nephropathy (7).